North America Medical Instrument Disinfection Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

North America Medical Instrument Disinfection Market Size

• The North America medical instrument disinfection market size was valued at USD 2.10 billion in 2025 and is expected to reach USD 3.68 billion by 2033, at a CAGR of 7.30% during the forecast period
• The market growth is largely fueled by the increasing number of surgical procedures and the growing emphasis on infection prevention and control practices across hospitals, ambulatory surgical centers, and diagnostic laboratories in the region
• Furthermore, rising regulatory standards for medical device reprocessing and the growing adoption of advanced automated washer-disinfectors and high-level disinfection systems are establishing medical instrument disinfection solutions as a critical component of modern healthcare infrastructure. These converging factors are accelerating the adoption of disinfection technologies, thereby significantly boosting the industry's growth

North America Medical Instrument Disinfection Market Analysis

• Medical instrument disinfection solutions, including disinfectant wipes, liquids, sprays, and automated disinfectors, are increasingly vital components of modern healthcare environments due to their critical role in preventing contamination and ensuring the safe reuse of medical and surgical instruments across hospitals, clinics, and laboratories.
• The escalating demand for medical instrument disinfection is primarily fueled by the rising number of surgical procedures, increasing awareness regarding infection prevention and control practices, and stringent regulatory requirements for the proper reprocessing and sterilization of reusable medical devices
• The United States dominated the North America medical instrument disinfection market with a revenue share of 78.4% in 2025, supported by advanced healthcare infrastructure, strict infection-control regulations, and widespread adoption of disinfectant products across hospitals and ambulatory surgical centers, along with increasing investments in automated disinfection technologies and infection prevention programs
• Canada is expected to witness the fastest growth in the North America medical instrument disinfection market during the forecast period, driven by expanding healthcare facilities, rising healthcare expenditure, and stronger initiatives aimed at improving hospital hygiene standards and infection control practices
• The Liquid segment dominated the market with a share of 41.6% in 2025, driven by its extensive use in healthcare facilities for intermediate- and high-level disinfection, compatibility with a wide range of medical instruments, and strong effectiveness in eliminating bacteria, viruses, and other pathogens during routine medical device reprocessing procedures

Report Scope and North America Medical Instrument Disinfection Market Segmentation    

North America Medical Instrument Disinfection Market Trends

Growing Adoption of Automated and High-Efficiency Disinfection Technologies

• A significant and accelerating trend in the North America medical instrument disinfection market is the increasing adoption of automated disinfection technologies and advanced chemical formulations designed to enhance infection prevention and improve operational efficiency across healthcare facilities
  • For instance, automated endoscope reprocessors and high-level disinfectors are increasingly being adopted by hospitals and surgical centers to ensure consistent, standardized, and traceable disinfection of reusable medical instruments
• Automation in medical instrument disinfection enables features such as controlled exposure times, automated dosing of disinfectants, and digital tracking of reprocessing cycles, which significantly reduce human error and enhance compliance with infection control guidelines. Furthermore, advanced formulations of liquid disinfectants provide broader antimicrobial coverage and faster action against resistant pathogens
• The integration of automated disinfectors with hospital infection control systems allows centralized monitoring of instrument reprocessing activities. Through digital interfaces, healthcare facilities can track disinfection cycles, maintain regulatory documentation, and improve workflow efficiency within sterile processing department
• This trend toward more efficient, standardized, and technologically advanced disinfection systems is reshaping expectations for healthcare safety and regulatory compliance. Consequently, companies such as advanced infection prevention solution providers are developing next-generation disinfection systems with automated workflows, faster cycle times, and enhanced microbial elimination capabilities
• The demand for high-performance disinfection solutions is growing rapidly across hospitals, ambulatory surgical centers, and diagnostic laboratories as healthcare providers increasingly prioritize infection prevention, regulatory compliance, and operational efficiency
• Growing investments in hospital sterilization infrastructure and expansion of sterile processing departments across major healthcare institutions are further accelerating the adoption of advanced medical instrument disinfection solutions across North America

North America Medical Instrument Disinfection Market Dynamics

Driver

Rising Surgical Procedures and Increasing Focus on Infection Prevention

• The increasing volume of surgical procedures across hospitals and ambulatory surgical centers, coupled with the growing emphasis on infection prevention and patient safety, is a significant driver for the heightened demand for medical instrument disinfection solutions
  • For instance, healthcare institutions across the United States continue to expand sterile processing capabilities and adopt advanced disinfection systems to ensure proper reprocessing of reusable medical instruments and compliance with strict infection control standards
• As healthcare providers become more focused on reducing hospital-acquired infections and improving patient outcomes, high-level disinfectants, wipes, sprays, and automated disinfectors provide reliable and standardized methods for eliminating pathogens from surgical and diagnostic instruments
• Furthermore, strict regulatory guidelines from health authorities and infection control organizations are encouraging healthcare facilities to adopt advanced disinfection technologies that ensure safe reuse of medical devices and minimize cross-contamination risks
• The convenience of ready-to-use disinfectant wipes, rapid-acting liquid formulations, and automated disinfection systems are key factors propelling the adoption of instrument disinfection products in hospitals, diagnostic laboratories, and outpatient care facilities. The increasing number of healthcare facilities and growing awareness regarding hygiene standards further contribute to market growth
• In addition, the growing prevalence of chronic diseases and aging populations in North America is leading to higher hospitalization and surgical rates, which directly increases the demand for effective instrument reprocessing and disinfection solutions
• Rising investments in healthcare infrastructure and infection prevention programs by hospitals and government agencies are further strengthening the adoption of advanced disinfection technologies across healthcare facilities

Restraint/Challenge

Chemical Exposure Risks and Strict Regulatory Compliance Requirements

• Concerns surrounding the potential health risks associated with prolonged exposure to certain chemical disinfectants pose a significant challenge to broader market adoption. Some disinfectant formulations may cause skin irritation, respiratory discomfort, or environmental concerns if not handled properly
  • For instance, healthcare workers involved in frequent instrument reprocessing may experience skin or respiratory irritation from repeated exposure to certain high-level disinfectant chemicals, prompting healthcare facilities to adopt stricter safety measures and handling protocols
• Addressing these concerns through the development of safer, low-toxicity disinfectant formulations and improved ventilation systems in sterile processing departments is crucial for ensuring worker safety and regulatory compliance. Manufacturers are increasingly focusing on eco-friendly and less hazardous disinfectant solutions
• In addition, stringent regulatory approval processes and compliance requirements from health authorities can slow the introduction of new disinfection products and technologies into the market, requiring extensive testing and documentation
• While healthcare facilities recognize the importance of effective disinfection, the costs associated with advanced automated disinfection equipment and regulatory compliance can create barriers for smaller healthcare centers
• Moreover, improper handling or incorrect dilution of disinfectant chemicals can reduce their effectiveness, increasing the risk of incomplete disinfection and potential healthcare-associated infections if strict protocols are not followed
• Overcoming these challenges through safer formulations, technological innovation, improved training of healthcare staff, and regulatory alignment will be vital for sustained market growth

North America Medical Instrument Disinfection Market Scope

The market is segmented on the basis of type, environmental protection agency classification, product type, end-user, and distribution channel.

• By Type

On the basis of type, the North America medical instrument disinfection market is segmented into wipes, liquid, and sprays. The liquid segment dominated the market with the largest market revenue share of 41.6% in 2025, driven by its extensive use for high-level and intermediate-level disinfection of reusable medical instruments across hospitals and laboratories. Liquid disinfectants are widely preferred because they offer broad-spectrum antimicrobial activity and can effectively penetrate complex instrument surfaces and channels. Healthcare facilities often rely on liquid disinfectants for routine reprocessing procedures due to their strong compatibility with automated disinfectors and manual cleaning workflows. In addition, the availability of multiple formulations designed for specific pathogens and instrument materials further supports the dominance of this segment in the regional market.

The wipes segment is anticipated to witness the fastest growth rate from 2026 to 2033, fueled by increasing demand for convenient, ready-to-use disinfection solutions in healthcare environments. Disinfectant wipes reduce preparation time and minimize the risk of incorrect dilution associated with liquid disinfectants. Hospitals and clinics increasingly use wipes for rapid disinfection of smaller medical instruments and equipment surfaces between patient procedures. The growing emphasis on infection prevention protocols and faster turnaround time for instruments is further accelerating the adoption of disinfectant wipes across healthcare facilities.

• By Environmental Protection Agency Classification

On the basis of Environmental Protection Agency classification, the market is segmented into low level, intermediate level, and high level. The high-level disinfectants segment dominated the market with the largest revenue share in 2025, driven by their ability to eliminate a wide range of microorganisms including bacteria, viruses, fungi, and certain spores. High-level disinfectants are widely used for reprocessing critical and semi-critical medical devices such as endoscopes and surgical instruments. Healthcare facilities prioritize high-level disinfectants to ensure compliance with strict infection control standards and to reduce the risk of healthcare-associated infections. Their strong antimicrobial performance and compatibility with automated disinfection systems further support their extensive use across hospitals and laboratories.

The intermediate-level disinfectants segment is expected to witness the fastest growth during the forecast period, driven by increasing use for routine disinfection of medical instruments and equipment that do not require full sterilization. These disinfectants are effective against a broad range of pathogens including mycobacteria and viruses, making them suitable for many clinical applications. The rising emphasis on routine infection control practices and the growing number of outpatient procedures are contributing to increased adoption of intermediate-level disinfectants. Healthcare facilities also favor these solutions due to their balance between antimicrobial effectiveness and reduced chemical intensity.

• By Product Type

On the basis of product type, the market is segmented into disinfector and others. The disinfector segment dominated the market with the largest revenue share in 2025, driven by the increasing adoption of automated disinfection systems across hospitals and sterile processing departments. Automated disinfectors ensure consistent and standardized cleaning and disinfection processes, reducing the risk of human error during manual instrument reprocessing. Healthcare facilities are increasingly investing in these systems to improve efficiency, maintain compliance with regulatory standards, and enhance infection control practices. The ability of disinfectors to process large volumes of instruments within controlled cycles further strengthens their importance in modern healthcare environments.

The others segment is anticipated to witness the fastest growth from 2026 to 2033, supported by the growing demand for complementary disinfection products and accessories used alongside automated systems. These include manual cleaning tools, specialized disinfectant solutions, and supporting equipment used during instrument reprocessing. As healthcare facilities continue to expand their sterilization and disinfection infrastructure, the demand for such supporting products is increasing. In addition, the rising complexity of medical devices is encouraging healthcare providers to adopt multiple disinfection approaches, which contributes to the growth of this segment.

• By End-User

On the basis of end-user, the North America medical instrument disinfection market is segmented into hospitals, medical device manufacturers, pharma manufacturers, and laboratory. The hospitals segment dominated the market with the largest market revenue share in 2025, driven by the high volume of surgical procedures and the continuous need for reprocessing reusable medical instruments. Hospitals maintain strict infection prevention protocols and require reliable disinfection solutions to ensure patient safety. The presence of dedicated sterile processing departments and increasing investments in infection control technologies further support the strong adoption of medical instrument disinfectants within hospital settings.

The laboratory segment is expected to witness the fastest growth during the forecast period, fueled by the expanding number of diagnostic laboratories and research facilities across North America. Laboratories require regular disinfection of specialized instruments and testing equipment to maintain sterile working conditions and prevent contamination of samples. The increasing focus on clinical diagnostics, biotechnology research, and pharmaceutical testing is further driving the demand for effective disinfection solutions in laboratory environments.

• By Distribution Channel

On the basis of distribution channel, the market is segmented into tender and over the counter. The tender segment dominated the market with the largest revenue share in 2025, driven by large-scale procurement of disinfectant products and equipment by hospitals, government healthcare facilities, and institutional buyers. Tender-based procurement enables healthcare organizations to secure bulk quantities of disinfectants and disinfection systems at competitive prices while ensuring consistent supply. Many healthcare institutions in North America rely on formal procurement processes to purchase infection control products that meet regulatory and quality standards.

The over the counter segment is expected to witness the fastest growth from 2026 to 2033, driven by increasing availability of disinfectant products through medical supply stores and online healthcare distributors. Smaller healthcare facilities, laboratories, and clinics often prefer over-the-counter purchases for quick and flexible procurement of disinfection products. The growing expansion of e-commerce platforms and specialized medical supply retailers is also making it easier for healthcare providers to access a wide range of disinfectant solutions.

North America Medical Instrument Disinfection Market Regional Analysis

• The United States dominated the North America medical instrument disinfection market with a revenue share of 78.4% in 2025, supported by advanced healthcare infrastructure, strict infection-control regulations, and widespread adoption of disinfectant products across hospitals and ambulatory surgical centers, along with increasing investments in automated disinfection technologies and infection prevention programs
• Healthcare providers in the region place strong emphasis on effective sterilization and disinfection practices to prevent healthcare-associated infections, leading to widespread adoption of advanced disinfectants, automated disinfectors, and high-level disinfection systems across hospitals and laboratories
• This strong market position is further supported by the presence of well-established healthcare infrastructure, strict regulatory guidelines for infection control, and continuous investments in hospital sterilization technologies, establishing medical instrument disinfection solutions as a critical component of patient safety and clinical hygiene across the region.

U.S. Medical Instrument Disinfection Market Insight

The U.S. medical instrument disinfection market captured the largest revenue share of 78.4% in 2025 within North America, fueled by the high number of surgical procedures and the strong presence of advanced healthcare infrastructure. Healthcare providers are increasingly prioritizing strict infection control protocols and proper reprocessing of reusable medical devices to reduce healthcare-associated infections. The growing demand for high-level disinfectants, automated disinfectors, and ready-to-use disinfectant wipes further propels the industry. Moreover, stringent regulatory guidelines for medical device sterilization and the increasing adoption of advanced infection prevention technologies are significantly contributing to the market's expansion.

Canada Medical Instrument Disinfection Market Insight

The Canada medical instrument disinfection market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by increasing investments in healthcare infrastructure and strong infection prevention programs across hospitals and laboratories. The rising demand for efficient sterilization and disinfection processes is fostering the adoption of advanced disinfectants and automated disinfection systems. Canadian healthcare facilities also emphasize compliance with strict hygiene standards and regulatory frameworks to ensure patient safety. The growing number of diagnostic procedures and surgical interventions further supports the demand for reliable medical instrument disinfection solutions in the country.

Mexico Medical Instrument Disinfection Market Insight

The Mexico medical instrument disinfection market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by expanding healthcare infrastructure and improving hospital hygiene standards. Increasing awareness regarding infection control practices is encouraging healthcare providers to adopt advanced disinfectant products and instrument reprocessing technologies. The rising number of hospitals, diagnostic laboratories, and outpatient care facilities is also contributing to market growth. In addition, government initiatives aimed at strengthening healthcare quality and hospital sanitation are expected to further stimulate the demand for medical instrument disinfection solutions in Mexico.

North America Medical Instrument Disinfection Market Share

The North America Medical Instrument Disinfection industry is primarily led by well-established companies, including:

• 3M (U.S.)
• STERIS Corporation (U.S.)
• Ecolab Inc. (U.S.)
• Clorox Professional (U.S.)
• Diversey (U.S.)
• Xenex Disinfection Services (U.S.)
• Advanced Sterilization Products (ASP) (U.S.)
• Bioquell (U.S.)
• Medivators Inc. (U.S.)
• Midmark Corporation (U.S.)
• TOMI Environmental Solutions, Inc. (U.S.)
• Stericenter (SciCan Ltd.) (Canada)
• Metrex Research LLC (U.S.)
• Ruhof Corporation (U.S.)
• Nanosonics Inc. (U.S.)
• TBJ, Inc. (U.S.)
• CS Medical LLC (U.S.)
• Pure Processing (U.S.)
• Mettrica (U.S.)
• Helios UVC (U.S.)

What are the Recent Developments in North America Medical Instrument Disinfection Market?

• In September 2025, The Clorox Company’s professional division CloroxPro announced the launch of Screen+ Sanitizing Wipes, designed to safely disinfect sensitive electronic medical equipment such as touchscreens and medical devices used in healthcare environments. The wipes are formulated to effectively eliminate bacteria and viruses while remaining safe for delicate surfaces, supporting infection prevention protocols in hospitals and laboratories
• In July 2025, the U.S. Food and Drug Administration (FDA) implemented stricter clearance requirements for ultraviolet (UVC) disinfection devices used in healthcare facilities. The updated regulatory framework requires manufacturers to demonstrate proven safety and effectiveness before marketing these devices. The move is expected to strengthen infection control standards and improve the reliability of UV-based disinfection technologies used to disinfect medical equipment and healthcare environments
• In January 2024, the U.S. FDA officially recognized vaporized hydrogen peroxide (VHP) as an established sterilization method for medical devices. The decision acknowledges the technology’s safety and effectiveness in disinfecting and sterilizing reusable medical instruments. By formally recognizing VHP sterilization, the FDA aims to diversify sterilization options for healthcare facilities and reduce reliance on ethylene oxide sterilization methods
• In June 2023, Olympus Corporation announced the launch of its new ETD endoscope washer-disinfector, designed to improve the cleaning and high-level disinfection of endoscopes used in hospitals. The system provides automated reprocessing with faster cycle times and enhanced efficiency to ensure that endoscopes are thoroughly cleaned and disinfected before reuse. The development supports healthcare providers in complying with strict infection control protocols and reducing the risk of cross-contamination during endoscopic procedures
• In March 2022, Sterifre Medical announced plans to launch its Aura automated desktop disinfection device, which uses hydrogen peroxide technology to disinfect commonly used medical items such as stethoscopes, tablets, and other point-of-care equipment. The compact device automates the disinfection process and helps healthcare workers reduce contamination risks associated with frequently used clinical tools. The innovation reflects the growing trend toward portable and automated disinfection systems designed to improve hygiene and infection prevention within healthcare environments

SKU-17688